Thus, the downregulation of IL6, IL10, IL12, sICAM-1, sICAM-3, sPECAM-1, and CD40L secretion may lead to the melanoma progression and impair survival of the patients with metastatic melanoma. This evidence concerns the gene IL10 and melanoma.